Choosing Old and New Antiepileptic Drugs in Epilepsy Treatment

被引:0
作者
Bek, Semai [1 ]
Kasikci, Tayfun [1 ]
Koc, Guray [1 ]
Genc, Gencer [1 ]
Gokcil, Zeki [1 ]
Odabasi, Zeki [1 ]
机构
[1] Gulhane Mil Med Acad, Dept Neurol, TR-06018 Ankara, Turkey
关键词
Anticonvulsants; epilepsy; therapeutics;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: According to recent studies old antiepileptic drugs used without alternative in the treatment of epilepsy, seems to leave their place to new antiepileptic drugs during last two decades. The present study aimed to investigate whether the results of those studies hold any truth in clinical practice. Patients and Methods: Medical records of patients that present to our clinic with the diagnosis of epilepsy between 2001 and 2007 were investigated retrospectively. Results: Data on 1358 patients were evaluated. Among them, 1120 (82%) patients had monotherapy and 238 (18%) patients had polytherapy. The results were grouped by initial treatment dates: 552 of 603 (86%) patients used old antiepileptic drugs and 92 (14%) used new antiepileptic drugs between 2000 and 2007; 467 of 483 (95%) patients used old antiepileptic drugs and 24 (5%) used new antiepileptic drugs between 1995 and 1999; 270 of 272 (99%) used old antiepileptic drugs and 3 (1%) used new antiepileptic drugs prior to 1994. Conclusion: When the patients that received monotherapy were grouped by initial treatment dates the rate of new antiepileptic drug use was 10%, although old antiepileptic drugs were still the first choice. There was a significant increase in the use of new antiepileptic drugs as adjuvant treatment in patients with polytherapy in the last years.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 35 条
  • [1] Comparative epidemiology of epilepsy in Pakistan and Turkey: Population-based studies using identical protocols
    Aziz, H
    Guvener, A
    Akhtar, SW
    Hasan, KZ
    [J]. EPILEPSIA, 1997, 38 (06) : 716 - 722
  • [2] Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines
    Beghi, E
    [J]. LANCET NEUROLOGY, 2004, 3 (10) : 618 - 621
  • [3] Bek S, 2007, EPILEPSI, V13, P12
  • [4] Ben-Menachem Elinor, 2000, Current Opinion in Neurology, V13, P165, DOI 10.1097/00019052-200004000-00009
  • [5] The pharmacokinetics and interactions of new antiepileptic drugs - An overview
    Bialer, M
    [J]. THERAPEUTIC DRUG MONITORING, 2005, 27 (06) : 722 - 726
  • [6] Prevalence of epilepsy in Bursa City Center, an urban area of Turkey
    Calisir, Nermin
    Bora, Ibrahim
    Irgil, Emel
    Boz, Meral
    [J]. EPILEPSIA, 2006, 47 (10) : 1691 - 1699
  • [7] Erdogan E, 2007, UL KLIN NOR EEG EMG, P36
  • [8] Eroglu E, 2008, ACTA NEUROL BELG, V108, P53
  • [9] Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy - Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society
    French, JA
    Kanner, AM
    Bautista, J
    Abou-Khalil, B
    Browne, T
    Harden, CL
    Theodore, WH
    Bazil, C
    Stern, J
    Schachter, SC
    Bergen, D
    Hirtz, D
    Montouris, GD
    Nespeca, M
    Gidal, B
    Marks, WJ
    Turk, WR
    Fischer, JH
    Bourgeois, B
    Wilner, A
    Faught, RE
    Sachdeo, RC
    Beydoun, A
    Glauser, TA
    [J]. NEUROLOGY, 2004, 62 (08) : 1252 - 1260
  • [10] French JA, 2004, NEUROLOGY, V62, P1261, DOI 10.1212/01.WNL.0000123695.22623.32